Is Wall Street The Next Stop For Psychedelics? Investing In The Psychedelic Medicine Sector
This article was originally published on Psychedelic Spotlight and appears here with permission. Elemental Advisors Inc. CEO Tim…
Mindset Pharma Teams Up With The McQuade Center To Develop 2 Families Of Novel Psychedelic Compounds
This article was originally published on Psychedelic Spotlight and appears here with permission.
It’s yet another sign that the pharmaceutical industry at large is taking the potential of psychedelics very seriously.
Psyched: Atai Launches ‘Salvia Divinorum’ Subsidiary, Mindset, Psilera and Wesana’s Preclinical Trials, Origin Raises $5M
Atai Life Sciences Launches New Salvia Divinorum Subsidiary
Atai Life Sciences (NASDAQ: ATAI) announced the launch of a new subsidiary that will research Salvinorin A, the active compound in salvia divinorum, a hallucinogenic herb native to Central America.